IRCT20221002056073N1 IRCT 2022-10-09 Oroumia University of Medical Sciences Comparing of Gabapentin and Cinnarizine Effect on Tinnitus Comparing of Gabapentin and Cinnarizine Effect on Tinnitus in Patients with Sensorineural Hearing Loss 2022-10-23 anticipated 114 Complete https://irct.ir/trial/66199 interventional Randomization: Randomized, Blinding: Not blinded, Placebo: Not used, Assignment: Parallel, Purpose: Treatment, Randomization description: Patients will be grouped into two groups, A and B, where group A will receive Gabapentin and group B will receive Cinnarizine. In this way, the number between 1 and 114 will be applied to the patients in the order of entering the study, and then using the website https://www.graphpad.com/quickcalcs, a table of random numbers with two groups will be randomized online. We will create A and B with 57 numbers in each group from numbers 1 to 114. 3 Tinnitus. Intervention 1: Intervention group: Cap Gabapentin 100mg/d 1st week, 300mg/d 2nd week (100mg q8h), 900mg/d 3th and 4th weeks (300mg q8h), 300mg/d 5th week (100mg q8h), 100mg/d 6th week- oral administration. Intervention 2: Control group: Tab Cinnarizine 25mg/d 1st week, 50mg/d 2nd week (25mg q12h), 75mg/d 3th and 4th weeks (25mg q8h), 50mg/d 5th week (25mg q12h), 25mg/d 6th week- oral administration. Undecided - It is not yet known if there will be a plan to make this available Justification or reason for indecision in sharing IPD is Need to refer to other studies that have been conducted and Studies in progress in order to consolidate with the present study with an acceptable statistical population and, if necessary, use meta-analysis or systematic studies to generalize to the appropriate statistical population for use by doctors and patients.